{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:22:07Z","timestamp":1792153327564,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632023FY03"],"award-info":[{"award-number":["2632023FY03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52173294"],"award-info":[{"award-number":["52173294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473161"],"award-info":[{"award-number":["52473161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273162"],"award-info":[{"award-number":["52273162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.actbio.2025.02.039","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:36:02Z","timestamp":1739993762000},"page":"399-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy"],"prefix":"10.1016","volume":"196","author":[{"given":"Changshun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4017-9722","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2025.02.039_bib0001","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2025.02.039_bib0002","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.actbio.2025.02.039_bib0003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0004","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0006","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2025.02.039_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41575-022-00738-z","article-title":"Improving IBD outcomes in the era of many treatment options","volume":"20","author":"Kobayashi","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41575-021-00574-7","article-title":"Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease","volume":"19","author":"Verstockt","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113887","article-title":"Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases","volume":"176","author":"Zu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.02.039_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/D3TB02302H","article-title":"Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: Latest advances","volume":"12","author":"Hu","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2025.02.039_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202304815","article-title":"Anti-inflammatory glycocalyx-mimicking nanoparticles for colitis treatment: Construction and in vivo evaluation","volume":"62","author":"Yoo","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2025.02.039_bib0013","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3748\/wjg.v28.i18.1922","article-title":"Novel drug delivery systems for inflammatory bowel disease","volume":"28","author":"Yasmin","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0014","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","article-title":"Mechanisms of nanoparticle transport across intestinal tissue: An oral delivery perspective","volume":"17","author":"Ejazi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.02.039_bib0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.02.039_bib0016","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.apsb.2024.02.019","article-title":"Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives","volume":"14","author":"Ding","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2025.02.039_bib0017","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41551-024-01224-4","article-title":"Reinforcement of the intestinal mucosal barrier via mucus-penetrating pegylated bacteria","volume":"8","author":"Chen","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.actbio.2025.02.039_bib0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","article-title":"Beyond pegylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials","volume":"124","author":"Khutoryanskiy","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.02.039_bib0019","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between pegylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2025.02.039_bib0020","doi-asserted-by":"crossref","first-page":"25444","DOI":"10.1021\/acsami.6b08183","article-title":"Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers","volume":"8","author":"Shan","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2025.02.039_bib0021","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1021\/acs.chemrev.2c00344","article-title":"Zwitterionic biomaterials","volume":"122","author":"Li","year":"2022","journal-title":"Chem. Rev"},{"key":"10.1016\/j.actbio.2025.02.039_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102141","article-title":"Superhydrophilicity and strong salt-affinity: Zwitterionic polymer grafted surfaces with significant potentials particularly in biological systems","volume":"278","author":"Li","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2025.02.039_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102848","article-title":"Surface design of nanocarriers: Key to more efficient oral drug delivery systems","volume":"313","author":"Spleis","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2025.02.039_bib0024","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.1039\/D1CS00658D","article-title":"Bioinspired dopamine and zwitterionic polymers for non-fouling surface engineering","volume":"50","author":"Asha","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2025.02.039_bib0025","doi-asserted-by":"crossref","first-page":"51650","DOI":"10.1021\/acsami.3c07658","article-title":"Betaine-based and polyguanidine-inserted zwitterionic micelle as a promising platform to conquer the intestinal mucosal barrier","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2025.02.039_bib0026","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","article-title":"Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions","volume":"15","author":"Han","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2025.02.039_bib0027","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsnano.2c08434","article-title":"In situ polymerization of zwitterions on therapeutic proteins to enable their effective oral delivery","volume":"17","author":"Fang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.02.039_bib0028","article-title":"Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers","volume":"19","author":"Ouyang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2025.02.039_bib0029","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.02.039_bib0030","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.apsb.2024.06.015","article-title":"Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation","volume":"14","author":"Zheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.actbio.2025.02.039_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.02.039_bib0032","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/IJN.S257269","article-title":"The influence of nanoparticle properties on oral bioavailability of drugs","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.actbio.2025.02.039_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206821","article-title":"Oral delivery of sirna using fluorinated, small-sized nanocapsules toward anti-inflammation treatment","volume":"35","author":"Wei","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.02.039_bib0034","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/1061186X.2015.1086359","article-title":"Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids","volume":"23","author":"Yildiz","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2025.02.039_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.06.024","article-title":"Nanoparticle oral absorption and its clinical translational potential","volume":"360","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.02.039_bib0036","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17425247.2016.1114604","article-title":"Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases","volume":"13","author":"Youshia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2025.02.039_bib0037","doi-asserted-by":"crossref","first-page":"16297","DOI":"10.1021\/acsnano.4c05544","article-title":"Mucoadhesive mesalamine prodrug nanoassemblies to target intestinal macrophages for the treatment of inflammatory bowel disease","volume":"18","author":"Park","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.02.039_bib0038","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.2147\/IJN.S210655","article-title":"Platinum nanoparticles as a therapeutic agent against dextran sodium sulfate-induced colitis in mice","volume":"14","author":"Zhu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.actbio.2025.02.039_bib0039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jconrel.2021.04.026","article-title":"Oral delivery of micro\/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives","volume":"334","author":"Dos Santos","year":"2021","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2025.02.039_bib0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.xphs.2016.09.016","article-title":"Non-sink dissolution behavior and solubility limit of commercial tacrolimus amorphous formulations","volume":"106","author":"Trasi","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2025.02.039_bib0041","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/MIB.0b013e318281f362","article-title":"Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era","volume":"19","author":"Thin","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.actbio.2025.02.039_bib0042","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141964","article-title":"Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice","volume":"131","author":"Jha","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2025.02.039_bib0043","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acs.biomac.2c00216","article-title":"Impact of zwitterionic polymers on the tumor permeability of molecular bottlebrush-based nanoparticles","volume":"23","author":"Fujii","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2025.02.039_bib0044","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/la200227b","article-title":"Zwitteration as an alternative to pegylation","volume":"27","author":"Estephan","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2025.02.039_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301585","article-title":"Efficient therapy of inflammatory bowel disease (IBD) with highly specific and durable targeted ta2c modified with chondroitin sulfate (TACS)","volume":"35","author":"Song","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.02.039_bib0046","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1038\/s41467-024-52722-7","article-title":"Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication","volume":"15","author":"Cao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.02.039_bib0047","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2023.08.015","article-title":"Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitis","volume":"361","author":"Liu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2025.02.039_bib0048","doi-asserted-by":"crossref","first-page":"eado6798","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of M2 macrophage-mimetic janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2025.02.039_bib0049","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/gut.35.3.353","article-title":"Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis","volume":"35","author":"Pullan","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.actbio.2025.02.039_bib0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejpb.2020.08.017","article-title":"Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease","volume":"155","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2025.02.039_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302677","article-title":"Ursodeoxycholic acid-decorated zwitterionic nanoparticles for orally liver-targeted close-looped insulin delivery","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthc. Mater."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:57:16Z","timestamp":1762556236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S1742706125001321"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.039","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral delivery of ultra-small zwitterionic nanoparticles to overcome mucus and epithelial barriers for macrophage modulation and colitis therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}